GEODE CAPITAL MANAGEMENT, LLC - AVENUE THERAPEUTICS INC ownership

AVENUE THERAPEUTICS INC's ticker is ATXI and the CUSIP is 05360L205. A total of 18 filers reported holding AVENUE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of AVENUE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$22,000
-45.0%
84,0330.0%0.00%
Q1 2022$40,000
-42.9%
84,033
+8.6%
0.00%
Q4 2021$70,000
-44.0%
77,413
-8.2%
0.00%
Q3 2021$125,000
-37.2%
84,346
+6.0%
0.00%
Q2 2021$199,000
-75.2%
79,556
-40.0%
0.00%
Q1 2021$804,000
+7.9%
132,594
+5.9%
0.00%
Q4 2020$745,000
-41.2%
125,261
+7.0%
0.00%
Q3 2020$1,267,000
+0.7%
117,036
+0.2%
0.00%
Q2 2020$1,258,000
+101.0%
116,827
+66.6%
0.00%
Q1 2020$626,000
-51.9%
70,115
-48.4%
0.00%
Q4 2019$1,302,000
+222.3%
135,822
+100.3%
0.00%
Q3 2019$404,000
-5.4%
67,7980.0%0.00%
Q2 2019$427,00067,7980.00%
Other shareholders
AVENUE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
EMFO, LLC 24,000$12,0000.01%
Virtu Financial LLC 58,004$28,0000.00%
TWO SIGMA SECURITIES, LLC 52,813$25,0000.00%
B. Riley Wealth Advisors, Inc. 60,330$30,0000.00%
BNP PARIBAS FINANCIAL MARKETS 8$4,0000.00%
BANK OF AMERICA CORP /DE/ 104$00.00%
WELLS FARGO & COMPANY/MN 48,062$23,0000.00%
NORTHERN TRUST CORP 13,767$7,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 84,033$40,0000.00%
View complete list of AVENUE THERAPEUTICS INC shareholders